Sign Out
Bevacizumab Injection (r-DNA origin) concentrate for solution for intravenous (I.V) infusion.
Each ABEVMY 100 mg in 4 mL vial contains 100 mg of bevacizumab (25 mg/mL) concentrate for solution for intravenous infusion supplied in a single use vial.
Each ABEVMY 400 mg in 16 mL vial contains 400 mg of bevacizumab (25 mg/mL) concentrate for solution for intravenous infusion supplied in a single use vial.
ABEVMY is a biosimilar product.
Excipients/Inactive Ingredients: Trehalose Dihydrate, Sodium Phosphate, Polysorbate 20, Water for Injections.
Continue with Google